Last €75.48 EUR
Change Today +0.71 / 0.95%
Volume 2.1M
SAN On Other Exchanges
Symbol
Exchange
EN Paris
OTC US
BrsaItaliana
Frankfurt
NASDAQ GM
As of 11:39 AM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - sanofi (SAN)

Name (Connections)Board RelationshipsTitleKey Developments
Klaus Pohle Ph.D. 45 RelationshipsIndependent Director and Chairman of Audit CommitteeProbe of Sanofi-Aventis Sales Activities Expanded
04/21/05
Gérard van Kemmel 18 RelationshipsIndependent Director, Chairman of Compensation Committee, Member of Audit Committee and Member of Appointments & Governance Committee 
Christian Mulliez 18 RelationshipsDirector, Member of Audit Committee and Member of Compensation Committee 
Robert Castaigne 89 RelationshipsIndependent Director and Member of Audit Committee 
Carole Piwnica 51 RelationshipsIndependent Non-Executive Director and Member of Audit Committee 
Fabienne Lecorvaisier 18 RelationshipsIndependent Director and Member of Audit Committee 

Compensation Committee* - sanofi (SAN)

Name (Connections)Board RelationshipsTitle
Thierry Desmarest 127 RelationshipsDirector, Member of Compensation Committee, Member of Strategy Committee and Member of Appointments & Governance Committee
Jean-René Fourtou 58 RelationshipsIndependent Director, Member of Compensation Committee, Member of Strategy Committee and Member of Appointments & Governance Committee
Claudie Haigneré 34 RelationshipsIndependent Director, Member of Compensation Committee and Member of Appointments & Governance Committee
Christian Mulliez 18 RelationshipsDirector, Member of Audit Committee and Member of Compensation Committee
Gérard van Kemmel 18 RelationshipsIndependent Director, Chairman of Compensation Committee, Member of Audit Committee and Member of Appointments & Governance Committee
SAN Compensation vs. Industry
1.3M
418.8K
Chief Executive Officer
Share price activity for SANOFI (SAN)
52 Week Price Performance
SAN
Industry Average

Corporate Governance Committee* - sanofi (SAN)

Name (Connections)Board RelationshipsTitle
Thierry Desmarest 127 RelationshipsDirector, Member of Compensation Committee, Member of Strategy Committee and Member of Appointments & Governance Committee
Jean-René Fourtou 58 RelationshipsIndependent Director, Member of Compensation Committee, Member of Strategy Committee and Member of Appointments & Governance Committee
Claudie Haigneré 34 RelationshipsIndependent Director, Member of Compensation Committee and Member of Appointments & Governance Committee
Gérard van Kemmel 18 RelationshipsDirector, Member of Audit Committee and Member of Compensation Committee
Serge Weinberg 38 RelationshipsIndependent Director, Chairman of Compensation Committee, Member of Audit Committee and Member of Appointments & Governance Committee
Arthur Wellesley 69 Relationships--
SAN and Competitor
Insiders vs. External
Board
16%
84%
Sanofi
7%
93%
Gilead Sciences Inc.
8%
92%
Bayer AG
20%
80%
GlaxoSmithKline plc
8%
92%
Merck & Co. Inc.
13%
87%
Novo Nordisk A/S
Insiders
External Board Members

Executive Committee* - sanofi (SAN)

Name (Connections)Board RelationshipsTitle
Laurence Debroux 14 RelationshipsFormer Chief Strategic Officer, Senior Vice President and Member of the Executive Committee
Gilles Lhernould 11 RelationshipsSenior Vice President of Industrial Affairs and Senior Vice President of Corporate Social Responsibility
Xavier Moreno 39 RelationshipsFormer Chief Executive Officer Of Operational Division And Member Of Exectuive Committee
Management Effectiveness Relative to the Industry
Return on Equity
0.3x
Return on Assets
0.5x
Return on Total Capital
0.4x
TEV/Total Revenue(LTM)
0.4x

Advisory Committee* - sanofi (SAN)

Name (Board Relationships)/Title Board Affiliations
Gary Nabel 28 Relationships
Chairman of the Strategic Development & Scientific Advisory Council, Chief Scientific Officer and Senior Vice President
No other board affiliations
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SAN:FP €75.48 EUR +0.71

SAN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bayer AG €93.66 EUR +0.72
Gilead Sciences Inc $70.02 USD +0.74
GlaxoSmithKline PLC 1,559 GBp -4.50
Merck & Co Inc $56.37 USD +0.11
Novo Nordisk A/S kr235.60 DKK +4.90
View Industry Companies
 

Industry Analysis

SAN

Industry Average

Valuation SAN Industry Range
Price/Earnings 27.1x
Price/Sales 3.0x
Price/Book 1.7x
Price/Cash Flow 15.0x
TEV/Sales 2.3x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SANOFI, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.